Patients With Late-Adult-Onset Ulcerative Colitis Have Better Outcomes Than Those With Early Onset Disease

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 8, 2010, Pages

  Ha, Christina Y ^a,b   Newberry, Rodney D ^a   Stone, Christian D ^a   Ciorba, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Disease Outcomes; Late Onset; Therapy; Ulcerative Colitis

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; STEROID; ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; REMISSION; RETROSPECTIVE STUDY; STEROID THERAPY; SYSTEMIC THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADOLESCENT; AGE; COLITIS, ULCERATIVE; COMPLICATION; MIDDLE AGED; MORTALITY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955279759     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.03.022     Document Type: Article

References (46)

1. Loftus C.G., Loftus E.V., Harmsen W.S., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007, 13:254-261.
2. Zimmerman J., Gavish D., Rachmilewitz D. Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985, 7:492-498.
3. Carr N., Schofield P.F. Inflammatory bowel disease in the older patient. Br J Surg 1982, 69:223-225.
4. Brandt L.J., Boley S.J., Mitsudo S. Clinical characteristics and natural history of colitis in the elderly. Am J Gastroenterol 1982, 77:382-386.
5. Jones H.W., Hoare A.M. Does ulcerative colitis behave differently in the elderly?. Age Ageing 1988, 17:410-414.
6. Gupta S., Saverymuttu S.H., Hodgson H.J.F. Is the pattern of inflammatory bowel disease different in the elderly?. Age Ageing 1985, 14:366-370.
7. Myren J., Bouchier I.A., Watkinson G., et al. The OMGE multinational inflammatory bowel disease survey 1976-1986. A further report on 3175 cases. Scand J Gastroenterol 1988, 144:11-19.
8. Stonnington C.M., Phillips S.F., Melton L.J., et al. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987, 1987:4.
9. Watts J.M., De Dombal F.T., Watkinson G., et al. Early course of ulcerative colitis. Gut 1966, 7:16-31.
10. Sinclair T.S., Brunt P.W., Mowat N.A. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983, 85:1-11.
11. Winther K.V., Jess T., Langholz E., et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003, 125:1576-1582.
12. Toghill P.J., Benton P. Ulcerative colitis in elderly patients. Gerontol Clin 1973, 15:65-73.
13. Edwards F.C., Truelove S.C. The course and prognosis of ulcerative colitis. Gut 1963, 4:299-315.
14. Triantafillidis J.K., Emmanouilidis A., Pomonis E., et al. Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients. J Gastroenterol 2001, 36:312-316.
15. Piront P., Louis E., Latour P., et al. Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege. Gastroenterol Clin Biol 2001, 25:157-161.
16. Robertson D.J., Grimm I.S. Inflammatory bowel disease in the elderly. Gastrointest Clin North Am 2001, 30:409-426.
17. Tremaine W.J., Timmons L.J., Loftus E.V., et al. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease. Aliment Pharmacol Ther 2007, 25:1435-1441.
18. Moum B., Ekbom A., Vatn M.H., et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1997, 32:1005-1012.
19. Hadithi M., Cazemier M., Gerrit A.M., et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol 2008, 14:3183-3187.
20. Riegler G., Tartaglione M.T., Carratu R., et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis. Dig Dis Sci 2000, 45:462-465. Gruppo Italiano Studio Colon-Retto (GISC).
21. Grimm I.S., Friedman L.S. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 1990, 19:361-389.
22. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585.
23. Pawelec G. Immunosenescence: impact in the young as well as the old?. Mech Ageing Dev 1999, 108:1-7.
24. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585.
25. Hakim F.T., Gress R.E. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens 2007, 70:179-189.
26. Johnson S.A., Cambier J.C. Ageing, autoimmunity and arthritis: senescence of the B cell compartment-implications for humoral immunity. Arthritis Res Ther 2004, 6:131-139.
27. Zhang H.G., Grizzle W.E. Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am 2003, 23:83-102. vi.
28. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19:9A-13A.
29. Lichtiger S., Present D.H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990, 336:16-19.
30. Truelove S.C., Witts L.T. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955, 2:1041-1048.
31. Jang E.S., Lee D.H., Kim J., et al. Age as a clinical predictor of relapse after induction therapy in ulcerative colitis. Hepatogastroenterology 2009, 56:1304-1309.
32. Ananthakrishnan A.N., McGinley E.L., Binion D.G. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009, 15:182-189.
33. Ng S.C., Kamm M.A. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009, 15:935-950.
34. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
35. Gisbert J.P., Nino P., Cara C., et al. Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients. Aliment Pharmacol Ther 2008, 28:228-238.
36. Present D.H., Meltzer S.J., Krumholz M.P., et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989, 111:641-649.
37. Bouhnik Y., Lemann M., Mary J.Y., et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996, 347:215-219.
38. Faubion W.A., Loftus E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
39. Cerveny P., Bortlik M., Kubena A., et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007, 13:1244-1249.
40. Higgins P.D., Rubin D.T., Kaulback K., et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009, 29:247-257.
41. Barrett J.C., Lee J.C., Lees C.W., et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009, 41:1330-1334.
42. Regueiro M., Kip K.E., Cheung O., et al. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:42-47.
43. Aldhous M.C., Drummond H.E., Anderson N., et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007, 102:589-597.
44. Dorshkind K., Montecino-Rodriguez E., Signer R.A.J. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 2009, 9:57-62.
45. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of aging. J Pathol 2007, 211:144-156.
46. Linton P.J., Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5:133-139.